↓ Skip to main content

Derlin-1, as a Potential Early Predictive Biomarker for Nonresponse to Infliximab Treatment in Rheumatoid Arthritis, Is Related to Autophagy

Overview of attention for article published in Frontiers in immunology, January 2022
Altmetric Badge

Citations

dimensions_citation
5 Dimensions

Readers on

mendeley
10 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Derlin-1, as a Potential Early Predictive Biomarker for Nonresponse to Infliximab Treatment in Rheumatoid Arthritis, Is Related to Autophagy
Published in
Frontiers in immunology, January 2022
DOI 10.3389/fimmu.2021.795912
Pubmed ID
Authors

Yongsong Cai, Ke Xu, Yirixiati Aihaiti, Zhijin Li, Qiling Yuan, Jing Xu, Haishi Zheng, Mingyi Yang, Bo Wang, Yanni Yang, Yin Yang, Peng Xu

Timeline

Login to access the full chart related to this output.

If you don’t have an account, click here to discover Explorer

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 10 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 10 100%

Demographic breakdown

Readers by professional status Count As %
Student > Doctoral Student 1 10%
Student > Bachelor 1 10%
Professor 1 10%
Student > Ph. D. Student 1 10%
Student > Master 1 10%
Other 1 10%
Unknown 4 40%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 3 30%
Medicine and Dentistry 2 20%
Immunology and Microbiology 1 10%
Unknown 4 40%